Practice guidelines for the treatment of uncomplicated cystitis

Current Urology Reports

Volumn 2, Issue 4, 2001, Pages 326-329

  Warren, John W ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cystitis; Fosfomycin; Health Maintenance Organization; Nitrofurantoin; Urinary Tract Infection

Indexed keywords

COTRIMOXAZOLE; TRIMETHOPRIM; URINARY TRACT ANTIINFECTIVE AGENT;

ADULT; CYSTITIS; FEMALE; HUMAN; PRACTICE GUIDELINE; REVIEW; STANDARD;

ADULT; ANTI-INFECTIVE AGENTS, URINARY; CYSTITIS; FEMALE; HUMANS; PRACTICE GUIDELINES; TRIMETHOPRIM; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0035427913     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-001-0072-2     Document Type: Article

References (19)

1. US Department of Health and Human Services, Public Health Service, National Institutes of Health: The National Kidney and Urologic Diseases Advisory Board 1990 Long-Range Plan-Window on the 21st Century. Bethesda, MD: National Institutes of Health; NIH publication no. 90-583; 1990.
2. Patton JP, Nash DB, Abrutyn E: Urinary tract infection: economic considerations. Med Clin North Am 1991, 75:495–513.
3. Kunin CM: Urinary tract infections. Flow charts (algorithms) for detection and treatment. JAMA 1975, 233:458–462. DOI: 10.1001/jama.233.5.458
4. Berg AO: Variations among family physicians’ management strategies for lower urinary tract infection in women: a report from the Washington Family Physicians Collaborative Research Network. J Am Board Fam Pract 1991, 4:327–330.
5. Wigton RS, Longenecker JC, Bryan TJ, et al.: Variation by specialty in the treatment of urinary tract infection in women. J Gen Intern Med 1999, 14:491–494. DOI: 10.1046/j.1525-1497.1999.05398.x
6. Barry HC, Ebell MH, Hickner J: Evaluation of suspected urinary tract infection in ambulatory women: a cost-utility analysis of office-based strategies. J Fam Pract 1997, 44:49–60.
7. Warren JW, Abrutyn E, Hebel JR, et al.: Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999, 29:745–758. This is a systematic review of the copious literature reporting randomized controlled trials of treatment of uncomplicated UTIs.
8. 1996 ASCP Susceptibility Testing Group: United States geographic bacteria susceptibility patterns. Am J Clin Pathol 1998, 109: 144–152.
9. Jones RN, Kugler KC, Pfaller MA, et al.: Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997. Diagn Microbiol Infect Dis 1999, 35:55–63. DOI: 10.1016/S0732-8893(98)00158-8
10. Dyer IE, Sankary TM, Dawson JA: Antibiotic resistance in bacterial urinary tract infections, 1991 to 1997. West J Med 1998, 169:265–268.
11. Gupta K, Scholes D, Stamm WE: Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999, 281:736–738. In a retrospective review in an HMO, these authors documented a progressive rise in resistance to TMP/SMZ, from 8% in 1992 to 16% in 1996; resistance to nitrofurantoin and to ciprofloxacin remained at less than 2%. DOI: 10.1001/jama.281.8.736
12. Zhanel GG, Karlowsky JA, Harding GKM, et al.: A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. Antimicrob Agents Chemother 2000, 44:1089–1092. DOI: 10.1128/AAC.44.4.1089-1092.2000
13. Talan DA, Stamm WE, Hooton TM, et al.: Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women. A randomized trial. JAMA 2000, 283:1583–1590. DOI: 10.1001/jama.283.12.1583
14. McCarty JM, Richard G, Huck W, et al.: A randomized trial of ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Am J Med 1999, 106:292–299. DOI: 10.1016/S0002-9343(99)00026-1
15. Wright SW, Wrenn KD, Haynes ML: Trimethoprim-sul-famethoxazole resistance among urinary coliform isolates. J Gen Intern Med 1999, 14:606–609. This is a retrospective case control study seeking risk factors for TMP/ SMZ resistance among patients with UTIs (cystitis and, apparently, acute pyelonephritis) and identified diabetes, recent hospitalization, and the use of antibiotics (particularly TMP/SMZ) as independent risk factors. DOI: 10.1046/j.1525-1497.1999.10128.x
16. Ena J, Amador C, Martinez C, de la Tabla VO: Risk factors for acquisition of urinary tract infections caused by ciprofloxacin resistant Escherichia coli. J Urol 1995, 153:117–120. This case control study from Spain examines ciprofloxacin resistance causing UTIs in hospitalized patients and, using a multivariate analysis, found that risk factors were, first of all, previous use of quinolones, then urologic abnormalities, age 65 years or older, and use of a urinary catheter. DOI: 10.1097/00005392-199501000-00040
17. Saint S, Scholes D, Fihn SD, et al.: The effectiveness of a clinical practice guideline for the management of presumed uncomplicated urinary tract infection in women. Am J Med 1999, 106:363–641. DOI: 10.1016/S0002-9343(99)00122-9
18. O’Connor PJ, Solberg LI, Christianson J, et al.: Mechanism of action and impact of a cystitis clinical practice guideline on outcomes and costs of care in an HMO. Jt Comm J Qual Improv 1996, 22:673–682.
19. Hirst GHL, Ward JE: Clinical practice guidelines: reality bites. Med J Aust 2000, 172:287–291.